Open AccessUse of 99mTc-sestamibi SPECT/CT imaging in predicting the degree of pathological hyperplasia of the parathyroid gland: semi-quantitative analysis
Author(s) -
Junhao Ma,
Jun Yang,
Chuanzhi Chen,
Yimin Lu,
Zhuochao Mao,
Haohao Wang,
Yan Yang,
Zhongqi Li,
Weibin Wang,
Lisong Teng
Publication year - 2021
Publication title -
quantitative imaging in medicine and surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 21
eISSN - 2223-4292
pISSN - 2223-4306
DOI - 10.21037/qims-21-66
Subject(s) - medicine , pathological , hyperplasia , nuclear medicine , hyperparathyroidism , receiver operating characteristic , secondary hyperparathyroidism , parathyroid gland , technetium (99mtc) sestamibi , single photon emission computed tomography , radiology , pathology , parathyroid hormone , calcium , scintigraphy
Previous studies have demonstrated that 99m Tc-sestamibi ( 99m Tc-MIBI) Single-Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT) imaging is an effective isotopic technique for locating the parathyroid in secondary hyperparathyroidism (SHPT). This study aimed to explore further the correlation between 99m Tc-MIBI SPECT/CT imaging and SHPT to demonstrate the value of 99m Tc-MIBI SPECT/CT in evaluating the degree of pathological hyperplasia of the parathyroid gland (PG).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom